In my opinion, I think a second drug as a minimum will also be coming from BMSN. I truly believe that a few other medical occurrences were learned from the previous tests that were done on the BMSN HemaXellerate drug for stem cells. I say this because if you read the PR below, you will see that BMSN is now referring to HemaXellerate as HemaXellerate I™ as if there is now more than one: http://ih.advfn.com/p.php?pid=nmona&article=56150687
This means that we can presume that there is at least ”two” different types of HemaXellerate drugs that does at least ”two” different things to support the field of medicine. This means that if you consider all of what we all have been believing, we can multiply our thoughts and beliefs by ”two” as a minimum.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.